AnaptysBio (ANAB) Price-to-Earnings (P/E) Ratio
Price: $19.29
Market Cap: $591.56M
Avg Volume: 1.02M
Market Cap: $591.56M
Avg Volume: 1.02M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
AnaptysBio's P/E ratios across different time periods:
- TTM: -3.77
- Annual: -2.59
- Quarterly: -4.31
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 5.30
- Price-to-Sales (P/S) Ratio: 4.12
Annual Ratios
AnaptysBio Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-3.77
P/B Ratio (Annual)
5.30
P/S Ratio (Annual)
4.12
AnaptysBio Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -2.59 | 5.30 | 4.12 |
| 2023 | -3.52 | 6.55 | 33.61 |
| 2022 | -6.78 | 3.33 | 84.85 |
| 2021 | -16.67 | 2.67 | 15.09 |
| 2020 | -29.47 | 1.48 | 7.83 |
| 2019 | -4.52 | 1.09 | 54.96 |
| 2018 | -25.53 | 3.24 | 314.78 |
| 2017 | -66.26 | 6.48 | 199.24 |
| 2016 | -72.48 | 7.86 | 18.50 |
| 2015 | -44.52 | 5.68 | 13.69 |
| 2014 | 68.13 | 40.15 | 15.19 |
| 2013 | 0.00 | 0.00 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for ANAB.